CIR.L Share News (CIR)

Circassia Loss Widens On Higher Costs As Allergy Programmes Progress

LONDON MARKET CLOSE: Oil Recovers As US Inflation Supports Fed Hike

FTSE 250 movers: Broker notes spur on big movers

(ShareCast News) - The FTSE 250 looks to finish the day in the green, with the second-tier market up 228.85 point (1.36%) to 17,001.42 mid-afternoon Tuesday. Circassia Pharmaceuticals rose to the top of the ranks after RBC Capital Markets initiated coverage at 'top pick' for the company. "With intr

BROKER RATINGS SUMMARY: Berenberg Upgrades Meggitt To Buy From Hold

Circassia appoints new non-exec director

(ShareCast News) - Marvin Samson has been appointed as non-executive director of Circassia Pharmaceuticals, the FTSE 250 group said on Tuesday. Samson, the founder and current chief executive of Samson Medical Technologies, currently holds the role of non-executive director at Antares Pharma, Flynn

LONDON MARKET MIDDAY: Heightened Geopolitical Risk Weighs On Shares

WINNERS & LOSERS SUMMARY: Travel Stocks Hit By US Travel Alert

Circassia Pharmaceuticals Wins Approval For FLIXOTIDE pMDi Equivalent

Circassia confident of meeting annual targets as sales rise in first nine months of 2015

(ShareCast News) - Circassia Pharmaceuticals said it was confident of meeting its full-year expectations after sales of its asthma treatment rose in the latest quarter and in the first nine months of the year. In a trading update released on Tuesday, the FTSE 250 group said in the first nine months

Circassia Pharmaceuticals Sales Up In Quarter, Confident On Full Year

Imperial Innovations Confident Portfolio Companies Will Go Public

DIRECTOR DEALINGS: Circassia Pharmaceuticals Non-Executive Sells

LONDON MARKET CLOSE: Stocks Down As Fed's Hold Creates Uncertainty

TOP NEWS SUMMARY: UK Service Sector Growth Weakest Since 2013

LONDON BRIEFING: easyJet Leads Positive Open After Strong Summer